(Q42269490)

English

Combination of E2F-1 promoter-regulated oncolytic adenovirus and cytokine-induced killer cells enhances the antitumor effects in an orthotopic rectal cancer model

scientific article published on 14 September 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Combination of E2F-1 promoter-regulated oncolytic adenovirus and cytokine-induced killer cells enhances the antitumor effects in an orthotopic rectal cancer model (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

oncolytic virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

object named as

Li Li

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

Yang Yan

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Yingxin Xu

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Yunshan Zhao

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Peiming Sun

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hailiang Liu

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Qinghao Fan

7

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Kai Liang

8

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Wentao Liang

9

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Huiwei Sun

10

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Xiaohui Du

11

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Rong Li

12

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

publication date

14 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1113-1122

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

An update on the surgical management of rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effect.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor--armed oncolytic adenovirus for the treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Two hundred years of cancer research.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Randomized study of autologous cytokine-induced killer cell immunotherapy in metastatic renal carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying MDA-7/IL-24

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Cancer stem cell vaccination confers significant antitumor immunity

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Novel murine model for colon cancer: non-operative trans-anal rectal injection

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Animal model of para-aortic lymph node metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

A revised picture of the E2F transcriptional network and RB function

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

The Rb/E2F pathway: expanding roles and emerging paradigms

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

The RB and p53 pathways in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Impact of tumor microenvironment on oncolytic viral therapy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Oncolytic viruses: a novel form of immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC).

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Synergistic antitumor effects of immune cell-viral biotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Crosstalk between immune cell and oncolytic vaccinia therapy enhances tumor trafficking and antitumor effects

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

Macrophage metalloelastase (MME) as adjuvant for intra-tumoral injection of oncolytic adenovirus and its influence on metastases development

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1149-5

21 January 2018

An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoradiation of rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the E2F family in human gastrointestinal carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low rectal cancer: classification and standardization of surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alteration of gene expression in melanoma cells following combined treatment with E2F-1 and doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

E2F-1 transcription factor immunoexpression is inversely associated with tumor growth in colon adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An E2F-responsive replication-selective adenovirus targeted to the defective cell cycle in cancer cells: potent antitumoral efficacy but no toxicity to normal cell

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

E2F-1: a proliferative marker of breast neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

G1-S transition defects occur in most breast cancers and predict outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24037896

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-013-1149-5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42269490&oldid=2243703562"